Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Finished Goods (2016 - 2025)

Grifols' (GIFLF) quarterly Finished Goods came in at $1.0 billion in Q4 2025, down 9.25% on a YoY basis from $1.1 billion in Q4 2024, and down 9.25% quarter-over-quarter from $1.1 billion in Q4 2024.

Analysis

Grifols (GIFLF) Finished Goods (2016 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Finished Goods for 10 consecutive years, with $1.0 billion the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Finished Goods fell 9.25% year-over-year to $1.0 billion; the trailing twelve-month figure through Dec 2025 stood at $1.0 billion (down 9.25% YoY), and the FY2025 full-year result was $973.9 million, down 11.92% from the prior year.
  • Finished Goods declined to $1.0 billion in Q4 2025 per GIFLF's latest filing, from $1.1 billion in the prior quarter.
  • Across five years, Finished Goods topped out at $1.1 billion in Q4 2024 and bottomed at $679.5 million in Q4 2022.
  • Historically, Finished Goods has averaged $945.6 million across 5 years, with a median of $1.0 billion in 2025.
  • The sharpest annual moves came in 2022 and 2023: Finished Goods fell 20.09% in 2022, then jumped 60.26% in 2023.
  • Over 5 years, Finished Goods stood at $850.3 million in 2021, then declined by 20.09% to $679.5 million in 2022, then surged by 60.26% to $1.1 billion in 2023, then grew by 1.54% to $1.1 billion in 2024, then declined by 9.25% to $1.0 billion in 2025.
  • According to Business Quant data, Finished Goods over the past three periods registered $1.0 billion, $1.1 billion, and $1.1 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.00 Bn
Dec 31, 2024 1.11 Bn
Dec 31, 2023 1.09 Bn
Dec 31, 2022 679.51 Mn
Dec 31, 2021 850.34 Mn
Dec 31, 2020 708.36 Mn
Dec 31, 2019 570.63 Mn
Dec 31, 2018 500.67 Mn
Dec 31, 2017 561.99 Mn
Dec 31, 2016 506.45 Mn